AI-generated summary
The authors retrospectively compared postherpetic neuralgia rates in patients with herpes zoster who received low-level laser therapy within the first 5 days, during days 6 to 14, or not at all. They report that early treatment was associated with a significantly lower incidence of PHN at 1, 3 and 6 months, while later treatment showed a lower incidence only at 3 months. The authors note the study was retrospective, so randomized trials are still needed.
- Who or what was studied
- Patients with herpes zoster (shingles): 48 in the acute laser group, 48 in the subacute laser group and 154 in the control group
- Limits stated in the abstract
- The study is retrospective, lacks double-blind randomization, may be affected by placebo effect, and lacks standardized prospective evaluation measures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Control group, Confidence interval, Placebo effect. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.